Flora Growth Announces Results of 2024 Annual and Special Meeting of Shareholders

Core Points - Flora Growth Corp. held its 2024 Annual and Special Meeting of Shareholders, where several proposals were voted on by shareholders [2][5]. Proposal Summaries - Proposal 1: Election of four directors to the Board of Directors. The voting results were as follows: - Clifford Starke: 4,969,741 votes for, 97,612 against, 18,969 abstentions, 2,778,760 non-votes - Kevin Taylor: 4,931,118 votes for, 129,648 against, 25,556 abstentions, 2,778,760 non-votes - Edward Woo: 4,881,581 votes for, 179,654 against, 25,087 abstentions, 2,778,760 non-votes - Brendan Cahill: 5,001,476 votes for, 57,680 against, 27,166 abstentions, 2,778,760 non-votes [3][4]. - Proposal 2: Reappointment of Davidson & Company LLP as auditors for the fiscal year ending December 31, 2024. The voting results were 7,499,363 votes for, 323,623 against, and 42,096 abstentions [4]. - Proposal 3: Approval of an amendment to the Company's 2022 Incentive Compensation Plan to increase the number of shares from 950,000 to 2,500,000. The voting results were 4,776,425 votes for, 285,446 against, and 24,451 abstentions [4]. - Proposal 4: Approval of the grant of stock appreciation rights to the CEO and CFO. The voting results were 4,802,189 votes for, 253,288 against, and 30,845 abstentions [4]. - Proposal 5: Approval of the issuance of 635,363 shares to acquire the minority interest of TruHC Pharma GmbH. The voting results were 4,249,883 votes for, 184,837 against, and 26,704 abstentions [5]. Company Overview - Flora Growth Corp. is a leader in consumer-packaged goods and pharmaceutical distribution, serving all 50 states and 28 countries with over 20,000 points of distribution globally [6].